Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia
Clinical trial NCT04938115 · COMPLETED
Trial details
- NCT number
- NCT04938115
- Sponsor
- Hebei Senlang Biotechnology Inc., Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-10
- Primary completion
- 2023-05-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.